Jennifer A. Kearney

4.9k total citations
85 papers, 3.4k citations indexed

About

Jennifer A. Kearney is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Jennifer A. Kearney has authored 85 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cellular and Molecular Neuroscience, 45 papers in Molecular Biology and 45 papers in Psychiatry and Mental health. Recurrent topics in Jennifer A. Kearney's work include Neuroscience and Neuropharmacology Research (53 papers), Epilepsy research and treatment (45 papers) and Ion channel regulation and function (35 papers). Jennifer A. Kearney is often cited by papers focused on Neuroscience and Neuropharmacology Research (53 papers), Epilepsy research and treatment (45 papers) and Ion channel regulation and function (35 papers). Jennifer A. Kearney collaborates with scholars based in United States, Australia and Japan. Jennifer A. Kearney's co-authors include Nicole A. Hawkins, Miriam H. Meisler, Alfred L. George, Andrew Escayg, Carlos G. Vanoye, Christopher H. Thompson, Lyndsey L. Anderson, Bryan T. MacDonald, Roger L. Albin and Jeffrey D. Calhoun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jennifer A. Kearney

84 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer A. Kearney United States	34	1.9k	1.9k	1.3k	922	374	85	3.4k
Massimo Mantegazza France	36	2.5k 1.3×	2.5k 1.3×	2.0k 1.5×	906 1.0×	405 1.1×	92	4.5k
Stéphanie Schorge United Kingdom	29	1.8k 1.0×	1.6k 0.9×	629 0.5×	525 0.6×	389 1.0×	67	3.0k
Snezana Maljevic Germany	25	1.5k 0.8×	1.2k 0.7×	769 0.6×	577 0.6×	565 1.5×	52	2.3k
David N. Bowser Australia	21	1.3k 0.7×	1.4k 0.7×	697 0.5×	352 0.4×	81 0.2×	29	2.6k
Thomas Sander Germany	28	961 0.5×	843 0.5×	560 0.4×	565 0.6×	72 0.2×	52	2.2k
Steven J. Clapcote United Kingdom	25	1.5k 0.8×	806 0.4×	216 0.2×	574 0.6×	168 0.4×	49	2.5k
Tomoko Toyota Japan	31	1.5k 0.8×	818 0.4×	344 0.3×	850 0.9×	71 0.2×	87	2.8k
Kim L. Powell Australia	22	752 0.4×	915 0.5×	638 0.5×	133 0.1×	191 0.5×	47	1.8k
Eleonora Palma Italy	36	1.8k 0.9×	1.7k 0.9×	747 0.6×	180 0.2×	42 0.1×	93	3.3k
Paul R. Buckland United Kingdom	35	1.6k 0.8×	1.1k 0.6×	422 0.3×	1.0k 1.1×	61 0.2×	82	3.3k

Countries citing papers authored by Jennifer A. Kearney

Since Specialization

Citations

This map shows the geographic impact of Jennifer A. Kearney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer A. Kearney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer A. Kearney more than expected).

Fields of papers citing papers by Jennifer A. Kearney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer A. Kearney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer A. Kearney. The network helps show where Jennifer A. Kearney may publish in the future.

Co-authorship network of co-authors of Jennifer A. Kearney

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer A. Kearney. A scholar is included among the top collaborators of Jennifer A. Kearney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer A. Kearney. Jennifer A. Kearney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Lyndsey L., et al.. (2024). Preclinical Evidence for a Drug–Drug Interaction Between Cannabinol and Melatonin. Basic & Clinical Pharmacology & Toxicology. 136(1). e14120–e14120. 1 indexed citations

Anderson, Lyndsey L., et al.. (2024). A high seizure burden increases brain concentrations of specialized pro-resolving mediators in the Scn1a mouse model of Dravet syndrome. Prostaglandins & Other Lipid Mediators. 176. 106943–106943. 1 indexed citations

Barefield, David Y., Nicole A. Hawkins, Elizabeth M. McNally, et al.. (2023). Sex and Gene Influence Arrhythmia Susceptibility in Murine Models of Calmodulinopathy. Circulation Arrhythmia and Electrophysiology. 16(9). e010891–e010891.

Forrest, Marc P., Marc Dos Santos, Nicolas H. Piguel, et al.. (2023). Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub. Nature Communications. 14(1). 825–825. 10 indexed citations

Hawkins, Nicole A., Sunita N. Misra, Alexandra M Huffman, et al.. (2022). Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2a K1422E mice. Human Molecular Genetics. 31(17). 2964–2988. 18 indexed citations

Stowe, T. D., Andrew L. Young, John McLaughlin, et al.. (2022). Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates. Human Gene Therapy. 33(11-12). 579–597. 68 indexed citations

Kearney, Jennifer A., et al.. (2022). Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11. Mammalian Genome. 33(4). 565–574. 3 indexed citations

Hawkins, Nicole A., et al.. (2021). Enhanced Synaptic Transmission in the Extended Amygdala and Altered Excitability in an Extended Amygdala to Brainstem Circuit in a Dravet Syndrome Mouse Model. eNeuro. 8(3). ENEURO.0306–20.2021. 15 indexed citations

Nomura, Toshihiro, Nicole A. Hawkins, Jennifer A. Kearney, Alfred L. George, & Anis Contractor. (2019). Potentiating α ₂ subunit containing perisomatic GABA _A receptors protects against seizures in a mouse model of Dravet syndrome. The Journal of Physiology. 597(16). 4293–4307. 15 indexed citations

10.

Xu, Dan, Andrew P. Robinson, Toshiyuki Ishii, et al.. (2018). Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. The Journal of Experimental Medicine. 215(4). 1169–1186. 97 indexed citations

11.

Favero, Morgana, et al.. (2018). A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. Journal of Neuroscience. 38(36). 7912–7927. 101 indexed citations

12.

Thompson, Christopher H., Nicole A. Hawkins, Jennifer A. Kearney, & Alfred L. George. (2017). CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice. Proceedings of the National Academy of Sciences. 114(7). 1696–1701. 30 indexed citations

13.

Hawkins, Nicole A., Michael Lewis, Rebecca Hammond, James Doherty, & Jennifer A. Kearney. (2017). The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model. Scientific Reports. 7(1). 15327–15327. 24 indexed citations

14.

Kearney, Jennifer A.. (2013). Less is More: Reducing Tau Ameliorates Seizures in Epilepsy Models. Epiliepsy currents. 13(4). 184–185. 2 indexed citations

15.

Hawkins, Nicole A., Melinda S. Martin, Wayne N. Frankel, Jennifer A. Kearney, & Andrew Escayg. (2010). Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus. Neurobiology of Disease. 41(3). 655–660. 67 indexed citations

16.

Turnbull, Julie, Hannes Lohi, Jennifer A. Kearney, et al.. (2005). Sacred disease secrets revealed: the genetics of human epilepsy. Human Molecular Genetics. 14(17). 2491–2500. 63 indexed citations

17.

Spampanato, Jay, Jennifer A. Kearney, Gerald de Haan, et al.. (2004). A Novel Epilepsy Mutation in the Sodium ChannelSCN1AIdentifies a Cytoplasmic Domain for β Subunit Interaction. Journal of Neuroscience. 24(44). 10022–10034. 128 indexed citations

18.

Kearney, Jennifer A.. (2003). mGluRs: a target for pharmacotherapy in Parkinson disease. Experimental Neurology. 184. 30–36. 21 indexed citations

19.

Kearney, Jennifer A. & Roger L. Albin. (1999). Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study. Neuroscience. 95(2). 409–416. 11 indexed citations

20.

Kearney, Jennifer A., Kirk A. Frey, & Roger L. Albin. (1997). Metabotropic Glutamate Agonist-Induced Rotation: A Pharmacological, FOS Immunohistochemical, and [¹⁴C]-2-Deoxyglucose Autoradiographic Study. Journal of Neuroscience. 17(11). 4415–4425. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact